Simultaneous determination of dipyridamole and salicylic acid in human plasma by high performance liquid chromatography-mass spectrometry

Biomedical Chromatography

Volumn 22, Issue 2, 2008, Pages 149-156

  Wang, Na ^a   Xu, Fengguo ^a   Zhang, Zunjian ^a   Yang, Cheng ^a   Sun, Xiuhong ^a   Li, Jinheng ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b NANJING GENERAL HOSPITAL OF NANJING MILITARY COMMAND   (China)

Author keywords

Dipyridamole; HPLC ESI MS; Pharmacokinetics; Salicylic acid

Indexed keywords

COLUMN CHROMATOGRAPHY; ELECTRODEPOSITION; ELECTROSPRAY IONIZATION; HIGH PRESSURE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NEGATIVE IONS; PHARMACOKINETICS; PLASMA (HUMAN); POSITIVE IONS; SALICYLIC ACID;

DIPYRIDAMOLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-MASS SPECTROMETRIES; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-ELECTROSPRAY IONIZATION-MASS SPECTROMETRY; HUMAN PLASMAS; INTERNAL STANDARDS; LIQUID CHROMATOGRAPHY-ELECTROSPRAY IONIZATION-MASS SPECTROMETRIES; ROSIGLITAZONE; SIMPLE++; SIMULTANEOUS DETERMINATIONS;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; AMMONIUM ACETATE; DIAZEPAM; DIPYRIDAMOLE; METHANOL; ROSIGLITAZONE; SALICYLIC ACID;

ARTICLE; BLOOD SAMPLING; CALIBRATION; CHINESE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG STRUCTURE; ELECTROSPRAY; ELUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LIQUID LIQUID EXTRACTION; MALE; MASS SPECTROMETRY; NORMAL HUMAN; PH; SENSITIVITY ANALYSIS; VALIDATION PROCESS; VOLUNTEER;

EID: 39349114354     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.909     Document Type: Article

References (17)

1. Aldandashi S. Noor R, Wang CX, Uddin G and Shuaib A. Combination treatment with dipyridamole, aspirin, and tPA in an embolic model of stroke in rats. Experimental Neurology 2007; 205: 563-568.
2. Bjornsson TD and Mahony C. Clinical pharmacokinetics of dipyridamole. Thrombosis Research 1983; 4: 93-104.
3. Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Guidance for Industry, Bioanalytical Method Validation. US Department of Health and Human Services, May 2001.
4. Forbes CD et al. for the ESPS Investigators. Secondary stroke prevention with low-dose aspirin, sustained release dipyridamole alone and in combination. Thrombosis Research 1998; 92: S1-S6.
5. Jamieson DG, Parekh A and Ezekowitz MD. Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents. Journal of Cardiovascular Pharmacology and Therapeutics 2005; 10: 153-161.
6. Kunkel A and Watzig H. Pharmacokinetic investigations with direct injection of plasma samples: possible savings using capillary electrophoresis (CE). Archiv der Pharmazie 1999; 332: 175-178.
7. Lenz T and Wilson A. Clinical pharmacokinetics of antiplatelet agents used in the secondary prevention of stroke, clinical pharmacokinetics 2003; 42: 909-920.
8. Liu JH and Smith PC. Direct analysis of salicylic acid, salicyl acyl glucuronide, salicyluric acid and gentisic acid in human plasma and urine by high-performance liquid chromatography. Jounal of Chromatography B 1996; 675: 61-70.
9. Mongillo JA and Paul J. Determination of aspirin and its major metabolites in human urine by gas chromatography-mass spectrometry, II. Microchemical Jounal 1997; 55: 296-307.
10. Pedersen AK. Specific determination of dipyridamole in serum by high-performance liquid chromatography. Journal of Chromatography 1979; 162: 98-103.
11. Pirker R, Huck CW, Popp M and Bonn GK. Simultaneous determination of gentisic, salicyluric and salicylic acid in human plasma using solid-phase extraction, liquid chromatography and electrospray ionization mass spectrometry. Jounal of Chromatography B Analytical Technologies in the Biomedical Life Sciences 2004; 809: 257-264.
12. Siebert DM and Bochner F. Determination of plasma aspirin and salicylic acid concentr-ations after low aspirin doses by high-performance liquid chromatography with post-column hydrolysis and fluorescence detection. Journal of Chromatography 1987; 420: 425-431.
13. Steyn JM. Spectrofluorimetric determination of dipyridamole in serum - a comparison of two methods. Journal of Chromatography 1979; 164: 487-494
14. Weinberger J. Adverse effects and drug interactions of antithrombotic agents used in prevention of ischaemic stroke. Drugs 2005; 65: 461-471.
15. Wolfram KM and Bjornsson TD. High-performance liquid chromatographic analysis of dipyridamole in plasma and whole blood. Journal of Chromatography 1980; 183: 57-64.
16. Xuemei Huang, Guangjian Xiang, Guichun Guo and Ximing Wu. Determination of dipyridamol concentration in serum by HPLC. Chinese Journal of Hospital Pharmacy 2003; 11: 612-615.
17. Yamamoto E, Takakuwa S, Kato T and Asakawa N. Sensitive determination of aspirin and its metabolites in plasma by LC-UV using on-line solid-phase extraction with methylcellulose-immobilized anion-exchange restricted access media. Jounal of Chromatography B Analytical Technologies in the Biomedical Life Sciences 2007; 846: 132-138.